Alfredo J. Lucendo

Dr. Alfredo J. Lucendo

Hospital General de Tomelloso
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
CLChris A. Liacouras
Chris A. Liacouras
GFGlenn T. Furuta
Glenn T. Furuta
IHIkuo Hirano
Ikuo Hirano
DADan Atkins
Dan Atkins
SAStephen E. Attwood
Stephen E. Attwood
SASeema S. Aceves
Seema S. Aceves

1 April 2017 in United European Gastroenterology Journal
Verified
Journal Article
Open access
Alfredo J. LucendoAlfredo J. Lucendo
Alfredo J. Lucendo
JMJavier Molina‐Infante
Javier Molina‐Infante
AAAngel Arias
Angel Arias
UAUlrike von Arnim
Ulrike von Arnim
ABAlbert J Bredenoord
Albert J Bredenoord
SAStephen E Attwood
Stephen E Attwood
Introduction: Eosinophilic esophagitis (EoE) is one of the most prevalent esophageal diseases and the leading cause of dysphagia and food impaction in children and young adults. This underlines the importance of optimizing diagnosys and treatment of the condition, especially after the increasing amount of knowledge on EoE recently published. Therefore, the UEG, EAACI ESPGHAN, and EUREOS deemed it necessary to update the current guidelines regarding conceptual and epidemiological aspects, diagnosis, and treatment of EoE.Methods: General methodology according to the Appraisal of Guidelines for Research and Evaluation (AGREE) II and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used in order to comply with current standards of evidence assessment in formulation of recommendations. An extensive literature search was conducted up to August 2015 and periodically updated. The working group consisted of gastroenterologists, allergists, pediatricians, otolaryngologists, pathologists, and epidemiologists. Systematic evidence‐based reviews were performed based upon relevant clinical questions with respect to patient‐important outcomes.Results: The guidelines include updated concept of EoE, evaluated information on disease epidemiology, risk factors, associated conditions, and natural history of EoE in children and adults. Diagnostic conditions and criteria, the yield of diagnostic and disease monitoring procedures, and evidence‐based statements and recommendation on the utility of the several treatment options for patients EoE are provided. Recommendations on how to choose and implement treatment and long‐term management are provided based on expert opinion and best clinical practice.Conclusion: Evidence‐based recommendations for EoE diagnosis, treatment modalities, and patients’ follow up are proposed in the guideline.


1 March 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
Alfredo J. LucendoAlfredo J. Lucendo
Alfredo J. Lucendo
AAAngel Arias
Angel Arias
JGJesús González-Cervera
Jesús González-Cervera
JYJosé Luis Yagüe-Compadre
José Luis Yagüe-Compadre
DGDanila Guagnozzi
Danila Guagnozzi
JTJosé M. Tenias
José M. Tenias

1 January 2016 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
Alfredo J. LucendoAlfredo J. Lucendo
Alfredo J. Lucendo
AAAngel Arias
Angel Arias
JMJavier Molina-Infante
Javier Molina-Infante

1 December 2014 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
Alfredo J. LucendoAlfredo J. Lucendo
Alfredo J. Lucendo
AAAngel Arias
Angel Arias
JTJosé M. Tenias
José M. Tenias